Davenport, Iowa – August 25, 2025 – (PRESS ADVANTAGE) –
Amana Care Clinic is making strides in healthcare access by opening a new walk-in urgent care clinic in Muscatine, Iowa, while simultaneously boosting services at its Davenport location. This move is part of their mission to make healthcare more accessible in the Quad Cities area, providing quick and convenient medical care for minor health problems. The clinic is known for addressing a variety of issues, including common colds, minor cuts, burns, and more. This approach highlights their commitment to offering effective healthcare solutions to the community.
The Davenport health clinic has earned a reputation as a convenient and affordable alternative to traditional hospitals and emergency rooms, which can often mean long queues and high costs. By allowing patients to walk in without appointments, the clinic cuts down on wait times and speeds up the care process. This focus on efficiency and accessibility makes Amana Care a preferred destination for those needing urgent medical attention in the Quad Cities.
“Our move into Muscatine shows our ongoing dedication to providing quality, fast healthcare to the Quad Cities,” says Moutaz Kotob, PhD, a spokesperson for Amana Care Clinic. Their official website provides further details about the services offered and operational hours. The new Muscatine location will maintain the high standards familiar to patients at the Davenport clinic. The walk-in model continues to benefit patients, ensuring they receive the care they need without the hassle of scheduling an appointment. This operational style improves patient flow and guarantees that quality healthcare remains accessible to everyone.
The clinic offers treatment for a wide range of minor health issues, such as cuts, back pain, bites, burns, muscle strains, and sinus infections. Beyond these immediate care services, the clinic also provides comprehensive laboratory tests and X-rays, ensuring that patients receive full care under one roof. The goal is to meet the diverse medical needs of the community effectively.
Innovations in technology, such as an online reservation system and virtual visit options, are also being introduced. The reservation system lets patients save their place in line before they leave home, reducing unnecessary wait times upon arrival. This feature improves patient experience and helps manage the patient flow efficiently. Additionally, patients can learn more about updates and find discussions relevant to their healthcare needs on their Facebook page, or by following the clinic on Instagram. The online visit service allows patients to consult with medical professionals from their homes, which is particularly beneficial for those with mobility challenges or those preferring virtual consultations.
“Our objective is to make it as easy as possible for people in the Quad Cities to access healthcare,” explains Kotob, emphasizing how these advancements align with Amana Care’s mission. With its flexible walk-in model, the clinic accommodates different patient schedules, while continuing to deliver the high-quality care it is known for.
Amana Care Clinic’s expanded services in the Quad Cities demonstrate the clinic’s commitment to community health and wellness. By reducing barriers to medical care, the clinic aims to fill healthcare gaps and enhance patient satisfaction. The new Muscatine location sends a strong message of growth and commitment to residents, ensuring that quality and fast medical help are always available. More about these developments is featured on Amana Care’s Instagram page.
This new venture into Muscatine is a strategic move for Amana Care, a well-known urgent care clinic respected for its patient-centered approach. By expanding, the clinic strengthens its position as a crucial player in the Quad Cities healthcare network, constantly adapting to meet the changing needs of patients and the communities it serves. Offering a quicker and more accessible option compared to a hospital, Amana Care is there for immediate medical needs.
###
For more information about Amana Care Clinic – Davenport, contact the company here:
Amana Care Clinic – Davenport Moutaz Kotob, PhD (563) 388-7000 moutazk@amanacareclinic.com 2162 W Kimberly Rd Davenport, IA 52806
Oklahoma City, Oklahoma – August 25, 2025 – (PRESS ADVANTAGE) –
Cortes Law Firm is well-regarded in Oklahoma City for its trustworthy legal services, mainly focusing on probate, estate planning, and administration. As a key part of the local community, the firm aims to educate individuals and families about the complexities of Oklahoma probate law, showing its expertise and commitment to helping clients.
Guided by Stephen L. Cortes, who has over 20 years of experience, Cortes Law Firm Oklahoma is adept at handling the details of estate planning. The firm focuses on trusts, wills, and estate management to ensure that a client’s estate matters align with their personal wishes. Stephen L. Cortes shares, “Our aim is to demystify probate and estate planning for families across Oklahoma City, helping them safeguard their legacies with clarity and confidence.”
In Oklahoma, handling probate and estate planning can be challenging due to specific legal nuances. To address these complexities, the firm uses a hands-on approach, fostering long-term relationships by centering services around the client. Cortes Law Firm helps clients understand asset titling and prepare estate planning documents, ensuring a smooth transition of assets after one’s passing.
The probate process in Oklahoma County can be complicated by legal differences. The dedicated team at Cortes Law Firm is committed to guiding clients through these obstacles, offering clear and comprehensive support in navigating local probate court proceedings and laws.
Stephen L. Cortes, who previously served as General Counsel for Governor Henry, brings significant legal expertise to estate resolution and probate law. He notes, “Every family deserves an advocate who not only understands the law but understands their unique family circumstances and needs. At Cortes Law Firm, we provide that personalized attention.”
For families in Oklahoma City seeking legal advice with a focus on personalized service and reliable support, Cortes Law Firm stands out as a dependable partner. Its central location in the city makes consultation access convenient for local residents.
Beyond probate and estate planning, Cortes Law Firm Oklahoma provides a wide range of legal services to meet diverse client needs. Services include revocable living trusts, wills, powers of attorney, and help with guardianship and trust management. The firm equips clients with necessary legal tools to maintain their financial well-being and family peace.
The firm’s commitment to sharing knowledge is further shown through its popular YouTube channel, where Stephen Cortes offers insights on estate planning, probate processes, and related topics. These educational resources help inform families, enabling them to make knowledgeable decisions about their estates.
Residents interested in learning more about estate planning or probate processes are encouraged to use these resources. Those in Oklahoma City seeking legal proceedings or advice can reach out to seasoned attorneys at the firm.
For more details or to start securing the family’s future with the Cortes Law Firm, residents can contact (405) 213-0856 or visit the website. The firm’s dedication to clients and its wide range of services underline its reputation as a leader in the field.
###
For more information about Cortes Law Firm, contact the company here:
Cortes Law Firm Stephen Cortes 4052130856 info@corteslawfirm.com 5801 Broadway Extension Hwy Suite 110 Oklahoma City, OK, 73118
MIAMI BEACH, FL / ACCESS Newswire / August 25, 2025 / The Tripathi Foundation Inc. has released a draft manuscript introducing the Equation of Forces (EoF), a proposed unified law of nature that seeks to bring together gravity, electromagnetism, the strong and weak nuclear interactions, and quantum corrections within a single covariant framework.
The work, developed by Dr. GNR Tripathi and Pradeep Tripathi builds systematically from the history of unification – from Newton and Maxwell through Einstein, quantum field theory, and string theory – toward a modern synthesis designed to remain consistent across both classical and quantum regimes.
About the Equation of Forces
The EoF framework presents a single master equation with:
Integration of gravitational, gauge, scalar, and effective correction terms.
Structural safeguards enforcing causality, anomaly cancellation, positivity, and duality symmetries.
Reductions to known physical laws in the appropriate limits, while allowing for new, testable corrections.
The framework is not offered as a final theory, but as a carefully constructed draft for discussion and exploration. Its design emphasizes both consistency with established science and openness to empirical testing in gravitational-wave astronomy, cosmology, particle physics, and laboratory-scale precision experiments.
Continuing a Tradition
This work is presented with deep respect for the tradition of unification that has guided physics for centuries. Each step, from Newton’s universal gravitation to Maxwell’s unification of electricity and magnetism, from Einstein’s general relativity to the Standard Model of particle physics, has demonstrated that nature’s laws grow simpler and more coherent at deeper levels.
The Equation of Forces is offered in that same spirit – as a continuation of this ongoing search for unity, placed before the scientific community with humility and an openness to refinement, testing, and critique.
About the Tripathi Foundation Inc.
The Tripathi Foundation Inc. is dedicated to advancing fundamental inquiry in physics and supporting research that aims to deepen humanity’s understanding of the natural world. [Our apologies for incorrect page numbering.]
Marks a key milestone following the company’s public listing and continued growth as a U.S.-listed SAF company
Celebrates XCF’s mission to decarbonize the aviation industry through scalable, investor-grade SAF infrastructure
HOUSTON, TEXAS / ACCESS Newswire / August 25, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel (“SAF”), today announces it will ring the Nasdaq Stock Market Opening Bell this morning at Nasdaq’s iconic MarketSite in Times Square. The Opening Bell Ceremony will be broadcast live on the Nasdaq website and social media platforms.
The Opening Bell Ceremony marks a major milestone for XCF following its public listing earlier this year and highlights the company’s momentum in building a global platform of renewable fuel production facilities engineered to accelerate the decarbonization of the aviation industry through the adoption of SAF.
Mihir Dange, Chief Executive Officer and Board Chair of XCF Global commented:
“Becoming a publicly traded company on Nasdaq, one of the largest stock exchanges in the world, is a major milestone for XCF. But today’s ceremony is not just about what we’ve achieved – it’s about where we are going. SAF is fast becoming the defining market of the next decade, and XCF has the early-mover advantage to lead. With our flagship New Rise Reno facility at the core and an ambitious growth plan, we are proud to offer investors access to one of the most dynamic growth stories in renewable fuels. With its focus on growth and innovation, Nasdaq is the perfect home for XCF.”
XCF Global, Inc. is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry’s transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~153.2 million; 20% free float (as of August 25, 2025).
This Press Release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global’s expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the “Business Combination”), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global’s expenses resulting from potential inflationary pressures and rising interest rates, including manufacturing and operating expenses and interest expenses; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global’s offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global’s ability to meet Nasdaq’s continued listing standards; (6) XCF Global’s ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global’s ability to raise financing in the future and the terms of any such financing; (8) the New Rise Reno production facility’s ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (10) XCF Global’s ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (11) costs related to the Business Combination and the New Rise acquisitions; (12) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (13) XCF Global’s ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (14) changes in applicable laws or regulations; (15) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (16) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (17) the availability of tax credits and other federal, state or local government support; (18) risks relating to XCF Global’s and New Rise’s key intellectual property rights; (19) the risk that XCF Global’s reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (20) the effects of increased costs associated with operating as a public company; and (21) various factors beyond management’s control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global’s filings with the Securities and Exchange Commission (“SEC”), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global makes with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global’s expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.
Pairing sustainable materials with “physical-to-digital” authentication to validate recycled-content claim and EPR compliance.
NEW YORK, NY AND SINGAPORE / ACCESS Newswire / August 25, 2025 / SMX (Security Matters) PLC (NASDAQ:SMX; SMXWW), the pioneer of molecular “physical-to-digital” fingerprinting for supply-chain transparency, today announced a strategic collaboration with Bio-Packaging Pte Ltd, a Singaporean manufacturer of Polyethylene, Post-consumer recycle (PCR), biodegradable and certified-compostable general packaging. Established in 2007, Bio-Packaging serves supermarkets, food-service operators and retailers with ISO 14001-accredited, competitively priced solutions that combine quality, affordability and sustainable alternatives.
The collaboration embeds SMX’s invisible molecular marker into Bio-Packaging’s PCR, biodegradable and certified-compostable product lines during extrusion. Each scan-whether at production, distribution, point of sale or end-of-life-writes a tamper-proof “digital twin” to SMX’s blockchain platform, giving brand owners and regulators verified proof of origin, material type, recycling loops and composting outcomes in real time.
SMX believes that brands face growing scrutiny over ‘green’ labelling and packaging end-of-life performance. Integrating the SMX marker with Bio-Packaging’s green solutions can potentially turn every bag into a data-rich asset that proves its sustainability journey.
Lim Qin Jie, Director of Business Development of Bio-Packaging, added: “Our customers trust us for practical, cost-effective packaging that meets Singapore’s high environmental standards. By fusing SMX’s traceability technology with our PCR, biodegradable and compostable offerings, we can now deliver indisputable evidence that each product lives up to its eco-promise.”
Key Features of the Collaboration
Drop-in marking – SMX’s marker is added during films or bags production without altering the material’s performance.
Regulatory readiness – Data aligns with Singapore’s forthcoming Extended Producer Responsibility (EPR) scheme for packaging and designed to support global plastic-tax reporting.
Anti-greenwashing assurance – Embedded metadata to substantiate biodegradability and recycled-content claims, expecting to bolster consumer trust.
Looking Ahead
By empowering local converters with verifiable data, SMX and Bio-Packaging aim to accelerate Singapore’s transition to a zero-waste, high-value circular economy. SMX and Bio-Packaging will work with government agencies and industry groups to scale the platform across additional substrates and end-use sectors, with the goal to make transparent, accountable packaging the new norm across Asia-Pacific and then globally.
Follow us through our social channel @secmattersltd @smx.tech
About SMX
As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.
About Bio-Packaging
Founded in 2007 and headquartered at Woodlands Spectrum 1, Bio-Packaging Pte Ltd provides HDPE, PCR, biodegradable and certified-compostable carrier bags, produce rolls and industrial liners to supermarkets, food service, retail and industrial clients. The company is ISO 14001-certified and focuses on delivering high-quality, competitively priced, innovative and sustainable packaging solutions.
Forward-Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber, plastic and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.
CEO Dan O’Toole wants to pay and get paid in Bitcoin
INDIANAPOLIS, INDIANA / ACCESS Newswire / August 25, 2025 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network anchored by patented AI-powered Arrive Points™, is preparing to use Bitcoin cryptocurrency to pay its vendors, clients and employees who prefer it over traditional dollars.
“We think cryptocurrency is a better way to pay, and as we continue to expand our footprint globally, we think our associates will be happy to have this option,” said Arrive AI CEO Dan O’Toole, who will be the first staffer to accept his compensation in cryptocurrency.
O’Toole said he is following the cryptocurrency strategy model established by Micro Strategies.
“Longer term, we see the opportunity to go beyond Bitcoin by creating our own token, an Arrive Coin. It would be designed for use across our entire ecosystem: paying employees and contractors, rewarding loyal customers, settling vendor contracts, and even streamlining transactions within our delivery network. Because our business sits at the intersection of logistics and AI, a proprietary digital currency could enhance transparency, speed and efficiency while giving investors and users a stake in the growth of our platform.”
Additional uses for cryptocurrency the company will consider include keeping cash holdings in Bitcoin and instituting a Bitcoin-denominated At the Market (ATM) program to facilitate fundraising.
A 2024 Deloitte survey showed that more than 6,000 U.S. businesses accept bitcoin as a means of payment. An accompanying Deloitte perspective said crypto offers benefits that traditional currency doesn’t, including real-time and accurate revenue-sharing and enhanced transparency to facilitate back-office reconciliation.
Bitwage, an international payroll services provider, says savvy tech workers prefer cryptocurrency because of its real-time payments across international borders, elimination of some transaction fees and the potential for added value from bitcoin marketplace value, among other considerations. Bitwage said crypto particularly appeals to blockchain developers, remote tech workers and Web3 professionals. The organization cited a 2023 Deloitte report that found more than 60 percent of Millennials and Gen Z view crypto as a key part of the future financial system.
“We’re a tech company on the rise, and we need the absolute best minds in the AI space to help us continue to refine our platform and take advantage of AI-driven learnings as we go,” O’Toole said. “Offering compensation in cryptocurrency – and potentially our own Arrive Coin in the future – is another way to attract and retain those people.”
Arrive AI is in the process of tripling its staff to add artificial intelligence scientists, delivering on the company’s commitment to be AI first in its operation and deliverables. Other jobs will include software and product engineering, underscoring Arrive AI’s commitment to continuous refinements of its proprietary technology and patented products. Additional positions will support critical sales and marketing functions as the company prepares for widespread deployment.
A Q2 2025 North American CFO Signals survey, which polled 200 North American finance chiefs working at companies with at least $1 billion in revenues, showed that 99 percent of responding CFOs said they envisioned using cryptocurrency for business functions in the long term. Nearly a quarter of them said their companies will use crypto for either investments or payments within the next two years. Cited benefits included enhanced protection of customer privacy, improved cross-border transaction facilitation, attracting new customers, faster transactions, elimination of chargebacks, lower processing fees and greater payment volumes.
O’Toole said he also plans on using cryptocurrency as an investment opportunity for company cash on hand.
“Embracing the emergence of Bitcoin allows us to have an upside in balance sheet ‘cash’ which could be a great synergy in our economics,” he said.
-30-
About Arrive AI
Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com. See the company’s press kit here.
This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “considers”, “intends”, “plans”, “prepares”, “believes”, “potential”, “will”, “should”, “could”, “would”, “wants”, “optimistic”, “in the process of” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results, for example, whether the company’s implementation of its crypto strategy could be successful, whether the company will eventually follow through with its plan to use cryptocurrency in its operation, or whether it could be successful in adding ideal workforce, and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement and other filings with the Securities Exchange Commission, for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Breakthrough Therapy designation complements Rusfertide’s Orphan Drug and Fast Track designations, which together confer multiple benefits to the development program
U.S. New Drug Application filing for Rusfertide in polycythemia vera on track for Q4
NEWARK, CA / ACCESS Newswire / August 25, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or “the Company”) announced today that rusfertide, a potential first-in-class hepcidin-mimetic peptide, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the treatment of erythrocytosis in patients with polycythemia vera (PV). In 2020, rusfertide received Orphan Drug status and Fast Track designation. Breakthrough Therapy Designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies.1 Breakthrough Therapy Designation also conveys eligibility for priority NDA review1 and Orphan Drug Designation qualifies sponsors for various incentives including a potential for extended market exclusivity.2
Breakthrough designation for rusfertide was supported by positive 32-week data from the Phase 3 VERIFY study, which was presented as a late breaking abstract highlighting its practice-changing potential during the plenary session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
“We are very pleased with the FDA’s decision to grant Breakthrough Therapy Designation to rusfertide, which underscores its potential to demonstrate substantial improvement over available PV therapies,” said Dinesh V. Patel, Ph.D., President and Chief Executive Officer at Protagonist. We remain on track for NDA submission of rusfertide in polycythemia vera by the end of this year.”
“In the VERIFY Phase 3 trial, rusfertide demonstrated positive results across all primary and key secondary endpoints including hematocrit control, decreased phlebotomy dependence, and patient reported outcomes including improvement in fatigue,” said Arturo Molina, M.D., M.S., Chief Medical Officer at Protagonist. “The comprehensive data provide compelling evidence of the potential for rusfertide to address unmet medical needs in patients with PV who are unable to achieve adequate hematocrit control with standard of care or currently available treatments.”
Rusfertide is being co-developed with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered in 2024, under which Protagonist remains primarily responsible for development through NDA filing.
About VERIFY The Phase 3 VERIFY study (NCT05210790) is an ongoing, three-part, global, randomized, placebo-controlled study evaluating rusfertide in 293 patients with polycythemia vera over a 156-week period. The study is evaluating the efficacy and safety of once-weekly, subcutaneously self-administered rusfertide in patients with uncontrolled hematocrit who are phlebotomy dependent despite current standard of care treatment, which could include hydroxyurea, interferon and/or ruxolitinib. The primary endpoint of the study was the proportion of patients achieving a response during weeks 20-32, which was defined as the absence of “phlebotomy eligibility.” To meet phlebotomy eligibility, patients in the study were required to have: confirmed hematocrit ≥45% that was ≥3% higher than their baseline hematocrit value, or hematocrit ≥48%.
All patients have completed their participation in the randomized, placebo-controlled portion of the study evaluating the efficacy and safety of rusfertide plus current treatment versus placebo plus current treatment and are now in the open-label portion of the study.
About Protagonist Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application (NDA) for icotrokinra submitted to the FDA in July and the NDA submission for rusfertide expected by end of 2025. Icotrokinra (formerly, JNJ-2113), a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (“IL-23R”) is licensed to J&J Innovative Medicines (“JNJ”), formerly Janssen Biotech, Inc.. Following icotrokinra’s joint discovery by Protagonist and JNJ scientists pursuant to the companies’ IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with JNJ assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage drug discovery programs addressing clinically and commercially validated targets, including IL-17 oral peptide antagonist PN-881, an obesity triple agonist peptide PN-477, and the oral hepcidin program.
More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company’s website at https://www.protagonist-inc.com/.
Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the potential benefits of rusfertide and the timing of rusfertide regulatory submissions. In some cases, you can identify these statements by forward-looking words such as “anticipate,” “believe,” “may,” “will,” “expect,” or the negative or plural of these words or similar expressions. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, our ability to develop and commercialize our product candidates, our ability to earn milestone payments under our collaboration agreements with Janssen and Takeda, our ability to use and expand our programs to build a pipeline of product candidates, our ability to obtain and maintain regulatory approval of our product candidates, our ability to operate in a competitive industry and compete successfully against competitors that have greater resources than we do, and our ability to obtain and adequately protect intellectual property rights for our product candidates. Additional information concerning these and other risk factors affecting our business can be found in our periodic filings with the Securities and Exchange Commission, including under the heading “Risk Factors” contained in our most recently filed periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.
LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / August 25, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) and Mkango Resources Ltd. (AIM/TSX-V: MKA) (“Mkango”) are pleased to announce that Intelligent Lifecycle Solutions LLC (“ILS”) has formally commenced its stockpiling of feedstock initiative pursuant to the recently announced feedstock supply and pre-processing site share agreement between HyProMag USA LLC (“HyProMag USA” or the “Project”) and ILS. Pre-processing of the feedstock is expected to commence prior to December 31, 2025.
The stockpiling and pre-processing will take place at both the ILS sites in Williston, South Carolina and Reno, Nevada (the “ILS sites”). ILS is a global electronics recycling company processing electronic waste. It is a full-service IT asset disposition, electronics recycling and scrap purchasing company and is fully compliant in ISO 14001:2015, ISO 45001:2018 and “Responsible Recycling R2v3 Recycler” at its USA locations. Through ILS, HyProMag USA will provide full traceability on its products to support the “closed loop” circular economy and critical mineral supply chains within the United States.
Julian Treger, CoTec CEO commented:“This is another major milestone in the execution of the HyProMag USA project. Securing feedstock is key to the success of any recycling business and we are pleased to work with credible companies such as ILS. HyProMag USA’s target is to secure between 6 months and 12 months of feedstock prior to commissioning of HyProMag USA’s advanced stage rare earth magnet recycling and manufacturing plant to be located in Dallas-Fort Worth, Texas. HyProMag USA aims to become a major contributor to the USA supply chain of rare earth magnets, a critical input for accelerating the reshoring of the U.S industrial base.”
Will Dawes, Mkango CEO commented: “The agreement with ILS and commencement of stockpiling of NdFeB feedstock underpins the rapid deployment of Hydrogen Processing of Magnet Scrap (HPMS) and associated magnet manufacturing into the United States by HyProMag USA, with detailed engineering well underway following the positive feasibility study last year. These developments will catalyse development of a more robust rare earth supply chain, whilst unlocking new NdFeB scrap sources in the United States and generating significant value for HyProMag USA and its stakeholders.”
About HyProMag USA LLC.
HyProMag USA is owned 50:50 by CoTec and HyProMag Limited. HyProMag Limited is 100 per cent owned by Maginito (“Maginito”), which is owned on a 79.4/20.6 per cent basis by Mkango and CoTec.
CoTec is a publicly traded investment issuer listed on the Toronto Venture Stock Exchange (“TSX- V”) and the OTCQB and trades under the symbols CTH and CTHCF respectively. CoTec Holdings Corp. is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employs a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining, and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec’s strategic model delivers low capital requirements, rapid revenue generation, and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector.
Mkango is listed on the AIM and the TSX-V. Mkango’s corporate strategy is to become a market leader in the production of recycled rare earth magnets, alloys and oxides, through its interest in Maginito Limited (“Maginito”), which is owned 79.4 per cent by Mkango and 20.6 per cent by CoTec, and to develop new sustainable sources of neodymium, praseodymium, dysprosium and terbium to supply accelerating demand from electric vehicles, wind turbines and other clean energy technologies.
Maginito holds a 100 per cent interest in HyProMag and a 90 per cent direct and indirect interest (assuming conversion of Maginito’s convertible loan) in HyProMag GmbH, focused on short loop rare earth magnet recycling in the UK and Germany, respectively, and a 100 per cent interest in Mkango Rare Earths UK Ltd (“Mkango UK”), focused on long loop rare earth magnet recycling in the UK via a chemical route.
Maginito and CoTec are also rolling out HPMS recycling technology into the United States via the 50/50 owned HyProMag USA LLC joint venture company.
Mkango also owns the advanced stage Songwe Hill rare earths project in Malawi (“Songwe”) and the Pulawy rare earths separation project in Poland (“Pulawy”). Both the Songwe and Pulawy projects have been selected as Strategic Projects under the European Union Critical Raw Materials Act. Mkango has signed a Binding Combination Agreement with Crown PropTech Acquisitions to list the Songwe Hill and Pulawy rare earths projects on NASDAQ via a SPAC Merger.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (‘MAR’) which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.
This news release contains forward-looking statements (within the meaning of that term under applicable securities laws) with respect to Mkango and CoTec. Generally, forward looking statements can be identified by the use of words such as “plans”, “expects” or “is expected to”, “scheduled”, “estimates” “intends”, “anticipates”, “believes”, or variations of such words and phrases, or statements that certain actions, events or results “can”, “may”, “could”, “would”, “should”, “might” or “will”, occur or be achieved, or the negative connotations thereof. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Such factors and risks include, without limiting the foregoing, the delivery and effectiveness of the HDD magnet separation system built by Inserma, the results of the Accelerated Pilot Programme at UoB, the availability of (or delays in obtaining) financing to develop Songwe Hill, the Recycling Plants being developed by Maginito in the UK, Germany and the US (the “Maginito Recycling Plants”), governmental action and other market effects on global demand and pricing for the metals and associated downstream products for which Mkango is exploring, researching and developing, geological, technical and regulatory matters relating to the development of Songwe Hill, the ability to scale the HPMS and chemical recycling technologies to commercial scale, competitors having greater financial capability and effective competing technologies in the recycling and separation business of Maginito and Mkango, availability of scrap supplies for Maginito’s recycling activities, government regulation (including the impact of environmental and other regulations) on and the economics in relation to recycling and the development of the Maginito Recycling Plants, and Pulawy and future investments in the United States pursuant to the proposed cooperation agreement between Maginito and CoTec, cost overruns, complexities in building and operating the plants, and the positive results of feasibility studies on the various proposed aspects of Mkango’s, Maginito’s and CoTec’s activities. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company and CoTec disclaim any intention and assume no obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law. Additionally, the Company and CoTec undertake no obligation to comment on the expectations of, or statements made by, third parties in respect of the matters discussed above.
SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Jeff Keating, Jen Clarke, Devik Mehta UK: +44 20 3470 0470
Alternative Resource Capital Joint Broker Alex Wood, Keith Dowsing UK: +44 20 7186 9004/5
The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any equity or other securities of the Company in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States to, or for the account or benefit of, U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.
Company remains on path to compliance following progress on strategic initiatives
MIAMI, FLORIDA / ACCESS Newswire / August 25, 2025 / Safe & Green Holdings Corp. (Nasdaq:SGBX) (“Safe & Green” or the “Company”), a leading developer of sustainable solutions and modular infrastructure, today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an extension to regain compliance with Nasdaq’s continued listing requirements.
The Nasdaq Hearings Panel acknowledged the significant progress Safe & Green has made toward completing its previously announced reverse stock split and granted the Company additional time to finalize the process. Under the terms of the extension, Safe & Green must complete the reverse stock split and demonstrate a minimum bid price of at least $1.00 per share for ten consecutive trading sessions by September 22, 2025.
“We are pleased that Nasdaq has recognized the progress we have made and granted us additional time to complete the reverse stock split,” said Mike Mclaren, CEO of Safe & Green Holdings. “We remain confident in our ability to meet these requirements and to continue executing on our long-term growth strategy. This extension ensures we can maintain our Nasdaq listing, which is important to our investors and our business as we move forward.”
Safe & Green has already met prior milestones established by Nasdaq and continues to take steps to ensure full compliance with all listing requirements.
About Safe & Green Holdings Safe & Green Holdings Corp. is a leading provider of modular construction and sustainable infrastructure solutions, serving customers across multiple industries including healthcare, education, energy, and government. The Company’s subsidiaries focus on delivering innovative, cost-efficient, and environmentally conscious solutions that drive long-term value creation.
Safe Harbor Statement
Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
VANCOUVER, BC / ACCESS Newswire / August 25, 2025 / Avino Silver & Gold Mines Ltd. (TSX:ASM)(NYSE American:ASM)(FSE:GV6) (“Avino” or the “Company”), a long-standing silver producer in Mexico, is pleased to announce that the Company has acquired 100% ownership of its La Preciosa project (“La Preciosa“) by purchasing and extinguishing all of the outstanding royalties and contingent payment obligations (the “La Preciosa Obligations“), currently held by Deterra Royalties Limited (DRR) (“Deterra“) (collectively, the “Transaction“). The consideration for this royalty purchase is a $13.25 million upfront payment followed by an $8.75 million payment deferred for one year. This second payment was already accounted for in the existing royalty agreement with Deterra.
Highlights of this transaction:
Restores full value and control of La Preciosa
Optimizes financial structure
Enhances project economics
Reduces administrative burdens
Manageable impact on financial liquidity
“Avino has seized upon a unique opportunity to buy back all the royalties on La Preciosa” said David Wolfin, President and CEO. “This cornerstone asset is now materially unencumbered, and this transaction represents a unique investment opportunity for Avino, as operators rarely get the chance to increase project value through the purchase of previously-granted royalties. By eliminating the royalty burden immediately prior to commencing production, we believe we will generate meaningful returns on our investment by lowering La Preciosa’s operating cost profile, and ensuring that as much of La Preciosa’s value remains with the operator and its stakeholders. The incremental cash outlay of only US$13.25 million represents an acquisition that is accretive to Avino shareholders on a net asset value (NAV) per share basis. The current metal price environment has enabled Avino to generate significant profits and cash flows from its current Avino mine operations, leading to the strongest balance sheet in the Company’s history and granting the ability to pursue investment opportunities that enhance shareholder value such as this. I would like to thank Deterra for being great partners as our team continued to advance La Preciosa on its way to production and I am thrilled to have reached an agreement where it was a win for both parties.”
The La Preciosa Obligations are comprised of:
a cash payment of US$8.75 million, to be paid no later than 12 months after initial production at La Preciosa (the “Contingent Production Payment“);
a 1.25% net smelter returns royalty on the Gloria and Abundancia areas of La Preciosa, and a 2.00% gross value returns royalty on all other areas of La Preciosa; and
a payment of US$0.25 per silver equivalent ounce (subject to inflationary adjustment) of new mineral reserves (as defined by NI 43-101) discovered and declared outside of the current mineral resource area at La Preciosa, subject to a cap of US$50 million, with any such payments to be credited against any existing or future payments owing on the gross value returns royalty.
Background to the Transaction
The La Preciosa Obligations were initially issued to Coeur Mining, Inc. (“Coeur“) in connection with the acquisition of La Preciosa by Avino in March 2022. Details of the Company’s acquisition of La Preciosa are available on the Company’s website here. Following the acquisition, Coeur sold the La Preciosa Obligations to Trident Royalties Plc (“Trident“) in May 2023, with Deterra subsequently acquiring the La Preciosa Obligations by way of its acquisition of Trident in September 2024.
Transaction Consideration
Avino acquired the La Preciosa Obligations from Deterra for immediate cash consideration of US$13.25 million (the “Upfront Payment“), plus an additional US$8.75 million in cash payable on the one-year anniversary of the closing of the Transaction (the “Deferred Payment“). The Upfront Payment was funded with Avino’s existing cash on hand, which was approximately US$48 million, immediately prior to this acquisition. The Deferred Payment was structured to substantially mirror the pre-existing Contingent Production Payment which Avino expects to pay by the end of 2026, given that initial production at La Preciosa is targeted in late 2025. As such, Avino believes the net cash investment for the purchase and extinguishment of the La Preciosa Obligations to be the Upfront Payment, with the Contingent Production Payment already considered in the Company’s capital allocation for the coming years. The Deferred Payment is expected to be funded with cash on hand.
Transaction Rationale
Avino has made excellent progress advancing La Preciosa with first production expected by the end of 2025 and significant production growth expected in the years thereafter which will see La Preciosa become a cornerstone asset for the Company. La Preciosa is one of the largest undeveloped silver resources in Mexico (see current NI 43-101 Resource Estimate below)located adjacent to Avino’s existing mine and infrastructure. Eliminating the 1.25% net smelter returns royalty on the Gloria and Abunduncia veins and the 2.00% gross value returns royalty on the remainder of the La Preciosa resource will meaningfully lower La Preciosa’s cash production costs, as well as remove any future potential obligations if new reserves are discovered outside of the current resource area.
Notes:
The stated mineral resources are classified in accordance with the Canadian Institute of Mining, Metallurgy and Petroleum’s “CIM Definition Standards – For Mineral Resources and Mineral Reserves” and are more particularly described in the Company’s February 5, 2024 Prefeasiblity Study, available under the Company’s profile at www.sedarplus.ca.
Mineral resources for La Preciosa are estimated at a cut-off grade of 120 g/t AgEq.
Mineral resources for La Preciosa are estimated using a long-term silver price of US$19.00/oz and a long-term gold price of US$1,750/oz.
Mineral resources are not mineral reserves and do not have demonstrated economic viability.
Tonnage and metal content figures are expressed in thousands and may not add up due to rounding.
La Preciosa Development Update
As seen in our latest press release dated July 22, 2025, blasting and construction of the relatively short 360 meter San Fernando main access decline is underway, and equipment mobilization has been swift, allowing development to advance on plan. The new jumbo drill is working on this ramp as it progresses toward intercepting the Gloria and Abundancia veins. Recent photos showcasing the work at La Preciosa are available on the Avino website – click here to view them.
A surface drill has been deployed to La Preciosa and drilling is expected to continue until the end of October. The drilling information will be utilized in underground mine planning and 3D modelling. The Company is also planning to update the current mineral resource estimate for Avino and La Preciosa was well as releasing its first mineral reserve estimate at the same time as the Company has now met the requirements for a Producing Issuer under the NI 43-101 standards of disclosure for mineral projects.
A more comprehensive drilling update will be released in the coming weeks.
Qualified Person(s)
Peter Latta, P.Eng., MBA, Avino’s VP Technical Services, is a qualified person within the context of National Instrument 43-101, has reviewed and approved the technical data in this news release.
About Avino
Avino is a silver producer from its wholly owned Avino Mine near Durango, Mexico. The Company’s silver, gold and copper production remains unhedged. The Company intends to maintain long term sustainable and profitable mining operations to reward shareholders and the community alike through our growth at the historic Avino Property and the strategic acquisition of the adjacent La Preciosa which was finalized in Q1 2022. Avino has a large silver equivalent resource base with consolidated mineral resources of 277 million AgEq ounces in the measured and indicated mineral resource category and 94 million AgEq ounces in the inferred mineral resource category. Early in 2024, the pre-feasibility Study on the Oxide Tailings Project was completed. This study represents a key milestone in our growth trajectory. As part of Avino’s commitment to adopting sustainable practices, we have been operating a dry-stack tailings facility for more than two years with excellent results. We are committed to managing all business activities in a safe, environmentally responsible, and cost-effective manner, while contributing to the well-being of the communities in which we operate. We encourage you to connect with us on X (formerly Twitter) at @Avino_ASM and on LinkedIn at Avino Silver & Gold Mines. To view the Avino Mine VRIFY tour, please click here.
This news release contains “forward-looking information” and “forward-looking statements” (together, the “forward looking statements”) within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995. This information and these statements, referred to herein as “forward-looking statements” are made as of the date of this document. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to the Company’s payment of US$8.75 million in cash to Deterra within 12 months from Closing. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “envisages”, “assumes”, “intends”, “strategy”, “goals”, “objectives” or variations thereof or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are made as of the date of this news release. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the future circumstances, outcomes or results anticipated in or implied by such forward-looking statements will occur or that plans, intentions or expectations upon which the forward-looking statements are based will occur. While we have based these forward-looking statements on our expectations about future events at the date that such statements were prepared, the statements are not a guarantee that such future events will occur and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements.
Cautionary note to U.S. Investors concerning estimates of Mineral Reserves and Mineral Resources
All reserve and resource estimates reported by Avino were estimated in accordance with the Canadian National Instrument 43-101 and the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards. The U.S. Securities and Exchange Commission (“SEC”) now recognizes estimates of “measured mineral resources,” “indicated mineral resources” and “inferred mineral resources” and uses new definitions of “proven mineral reserves” and “probable mineral reserves” that are substantially similar to the corresponding CIM Definition Standards. However, the CIM Definition Standards differ from the requirements applicable to US domestic issuers. US investors are cautioned not to assume that any “measured mineral resources,” “indicated mineral resources,” or “inferred mineral resources” that the Issuer reports are or will be economically or legally mineable. Further, “inferred mineral resources” are that part of a mineral resource for which quantity and grade are estimated on the basis of limited geologic evidence and sampling. Mineral resources which are not mineral reserves do not have demonstrated economic viability.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
